PURPOSE: To provide a method for treating an anxiety by using an anxiolytic agent capable of differentiating the anxiety shown by a healthy living body from a morbid anxiety, and having a large margin between an anxiolytic dosage and a neurotoxic dosage. CONSTITUTION: This method for treating an anxiety is to administer (S)-(-)-α- ethyl-2-oxo-1-pyrrolidine acetamide in an amount necessary for the treatment of a patient requiring the treatment through an oral or a parenteral route. As the anxiety requiring the treatment, the anxiety caused by a stress after an acute trauma and the anxiety induced by the withdrawal of chronically administered benzodiazepine, are cited. The daily dose is 5-70 mg/kg, and an average dose of 250 mg twice daily is effective for alleviating the anxiety in human. This dosage does not develop an adverse effect on a memory even if slightly, and also not develop an awkward motor nerve disturbance.
METHOD FOR MEDICAL TREATMENT OF ANXIETY USING (S)-(-)-ALPHA-ETHYL-2-OXO-1- PYRROLIDINE ACETAMIDE